Beyond Air
Focus: Beyond Air is an Israeli biotech company focused on nitric oxide inhalation therapy for respiratory and infectious diseases. The company operates as a pre-revenue or early-stage clinical-focused biotech with a specialized platform technology.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
Open Jobs
5+1 this month
Stable — net +1 jobs in 30d
15 added, 14 removed. Backfill posture.
Should You Work at Beyond Air?
AI assessmentA high-risk, high-reward early-stage biotech for scientists/commercialization professionals betting on nitric oxide platform differentiation; not suitable for those seeking revenue stability or near-term catalysts.
Why Work Here
- Focused platform play in nitric oxide therapy with 10 active clinical programs across respiratory, infectious disease, and oncology indications—offering depth in a single mechanism
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LungFit™
Viral PneumoniaClinical Trials (1)
NCT04606407Inhaled NO for the Treatment of Viral Pneumonia in Adults
N/AHelp build intelligence for Beyond Air
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.